Navigation Links
Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
Date:10/27/2009

should not be regarded as a representation by Orexigen that any of its plans will be achieved. Actual results may differ from those set forth in this release due to the risk and uncertainties inherent in the Orexigen business, including, without limitation: additional analyses of data from the Empatic Phase 2B trial or Contrave Phase 3 trials and any other clinical trials of Empatic or Contrave may produce negative or inconclusive results, or may be inconsistent with previously announced results or previously conducted clinical trials; the FDA may not agree with the Company's interpretation of efficacy and safety results; earlier clinical trials may not be predictive of future results; Empatic or Contrave may not receive regulatory approval on a timely basis or at all, and the FDA may require Orexigen to complete additional clinical, non-clinical or other requirements prior to the submission or the approval of NDAs for either product candidate; the potential for adverse safety findings relating to Empatic or Contrave to delay or prevent regulatory approval or commercialization, or result in product liability claims, including serious adverse events that are not characterized by clinical investigators as possibly related to Empatic or Contrave and adverse events associated with the individual components of these product candidates; the third parties on whom Orexigen relies to assist with the development programs for Empatic or Contrave, including clinical investigators, contract laboratories, clinical research organizations and manufacturing organizations, may not successfully carry out their contractual duties or obligations or meet expected deadlines, and the quality or accuracy of the data or materials generated by such third parties may be of insufficient quality to include in the Company's regulatory submissions; the ability of Orexigen and its licensors to obtain, maintain and successfully enforce adequate patent and other intellectual property protection of i
'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule
2. Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)
3. Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
4. Orexigen(R) Therapeutics Schedules July 20, 2009 Teleconference and Webcast Discussion of Contrave(R) Phase 3 Results
5. Orexigen(R) Therapeutics Schedules September 30, 2009 Teleconference and Webcast to Discuss Phase 2b Trial Results From Second Obesity Drug Candidate, Empatic(TM)
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
11. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... FREMONT, Calif. , June 30, 2015 ... and specialty medicine, continues to grow and add customers ... than 40% of the 62 CTSAs awarded by the ... clinical research information management. This is among the largest ... "Our presence in the CTSA community keeps growing ...
(Date:6/30/2015)... way for people to keep their family safe, while also ... being introduced to the world via an Indiegogo crowdfunding ... which needs to be raised in order to bring the ... was inspired by the many scenarios people face in their ... While medical alert bracelets have been around for years, they ...
(Date:6/30/2015)... -- A new report released today from the Institute of ... and training opportunities to reduce barriers to the provision ... rates of CPR and AED use by bystanders remain ... States even though evidence indicates that its ... Cross strongly supports the IOM,s recommendation to encourage training ...
Breaking Medicine Technology:Velos continues adding CTSA customers - 40% now use Velos products 2Amyko Propels Medical Alert Bracelets Into the Modern Era 2New Recommendations in Cardiac Arrest Protocol Advocate for Increased CPR and AED Training to Improve U.S. Survival Rates 2New Recommendations in Cardiac Arrest Protocol Advocate for Increased CPR and AED Training to Improve U.S. Survival Rates 3New Recommendations in Cardiac Arrest Protocol Advocate for Increased CPR and AED Training to Improve U.S. Survival Rates 4
... Inc. announced today that it has received FDA 510(k) clearance ... Generator powers the Stretta® System for treatment of Gastroesophageal Reflux ... Incontinence or Bowel Control Disorder (BCD). "Today,s ... investment and design efforts by Mederi. The goal of the ...
... ClinOps is a specialized contract research organization with ... biostatistics and specialized clinical services. Emphusion targets development ... when these services are a key to success. ... effective immediately. "Through acquisition and internal ...
Cached Medicine Technology:Mederi Therapeutics Announces Receipt of FDA 510(k) Clearance for the MDRF1 Radiofrequency Generator 2ClinOps to Change Name to Emphusion 2
(Date:7/1/2015)... ... ... Thule Atmos X4 offers protection with minimal bulk. At the Thule Test Center™, ... Due to its Bi-ComponentArmor and ShockStop corners, it passed Thule’s 2 meter drop test, ... The Thule Atmos X4 has also been designed with function in mind. The ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... Nutritional Products ... of nutritional and beauty products, recently attended the 2015 ECRM Diet, Vitamin & Sports ... in the retail industry. The ECRM trade show allows companies the chance ...
(Date:7/1/2015)... ... July 01, 2015 , ... First Harvest ... a web-based resource where legal cannabis startups can interact with corporate ... and medical marijuana advocates looking to strategically enter and capitalize on growing and ...
(Date:7/1/2015)... and Copiague, NY (PRWEB) , ... July 01, ... ... provider of physical therapy and rehabilitation clinics throughout New York and New Jersey, ... York, incorporating it into its portfolio of state-of-the-art clinics. At this most recent ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... specializes in Middle eastern, Persian and Mediterranean foods and groceries. Persianbazzar.com has recently ... time for the BBQ season, http://persianbazzar.com added great product lines such ...
Breaking Medicine News(10 mins):Health News:NPI Meets With Top Retail Figures at ECRM Conference 2Health News:First Harvest Financial Partners in Launch of Legal Medical Cannabis Documentary Initiative 2Health News:First Harvest Financial Partners in Launch of Legal Medical Cannabis Documentary Initiative 3Health News:Professional Physical Therapy Acquires Copiague’s South Bay Sports & Physical Therapy, P.C. 2Health News:Persian Bazzar Now Announces the Addition of Golden Star Food and Kitchenware to their website. 2Health News:Persian Bazzar Now Announces the Addition of Golden Star Food and Kitchenware to their website. 3
... More than one in four elderly Americans lacked the capacity ... life, according to a study of 3,746 people to be published ... Those who had advance directives - including living wills or ... wanted most of the time, says lead author Maria Silveira, M.D., ...
... Guidelines based on national data point to those heart ... News) -- Who,s most at risk when undergoing the ... U.S. study may have come up with some answers ... the odds of death after angioplasty, also known as ...
... Orange, Calif., March 31, 2010 UC Irvine ... Center have again earned the Gold Seal of ... and accrediting body. Joint Commission certification recognizes ... accepted nationwide as benchmarks for superior patient care. ...
... ... , ... 31, 2010 -- Pat Heyward Canes, a new provider of fashion forward walking canes ... and women ranging from classic to whimsical. Made from performance materials, the canes can ...
... genetic blueprint for humans , WEDNESDAY, March 31 (HealthDay News) ... scientists muse on how far they,ve come and how far ... of the genome draft in 2001 permanently altered the scientific ... to come, according to scientists writing in the April 1 ...
... ... the world to AMD Alliance International,s first global film competition aimed at raising awareness of ... world for people over 50. AMD Alliance International (AMDAI) announced the winners of the contest ... (PRWEB) March ...
Cached Medicine News:Health News:More than one-quarter of elderly patients lack decision-making capacity at death 2Health News:More than one-quarter of elderly patients lack decision-making capacity at death 3Health News:New Insights Into Who's At Risk With Angioplasty 2Health News:New Insights Into Who's At Risk With Angioplasty 3Health News:Medical center's heart failure, stroke programs recertified by Joint Commission 2Health News:Pat Heyward Canes Unveils New Stylish Walking Cane Collection Just in Time for Mother's Day 2Health News:Human Genome Turns 10 2Health News:Human Genome Turns 10 3Health News:Winners Announced from AMD Alliance International Film Contest 2Health News:Winners Announced from AMD Alliance International Film Contest 3Health News:Winners Announced from AMD Alliance International Film Contest 4
... The SC-Acufix anterior cervical plate system ... a patented, integrated swivel, which provides for ... and prevents bone screw disengagement or backout. ... a secondary locking screw. Simply implant your ...
Relocatable frame has been designed specifically for fractionated stereotactic radiotherapy treatments. It provides a fast, non-invasive and reproducible fixation of the patient....
... consisting of one part only, is made of ... compressed Polyamide may be rotated and moved as ... sizes and shapes, as well. Moreover they secure ... in caudal direction, which is one of the ...
VG1 ALIF (Anterior) Anterior lumbar interbody fusion. Frozen freeze-dried preservation....
Medicine Products: